NCT04802876 2025-03-21ACROPOLISOLTI Breast Cancer Research GroupPhase 2 Active not recruiting184 enrolled
NCT05556200 2023-04-12A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILsSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2 Unknown58 enrolled
NCT05402722 2022-06-02Study of Eribulin in Combination With Anti-PD-1 Antibody in Patients With Metastatic Triple-Negative Breast CancerBeijing 302 HospitalPhase 2 Unknown30 enrolled